DeutschNewstral
Article
jdsupra.com on 2015-05-12 18:37
FDA Initiates Expedited Access Pathway Program for Medical Devices via Final Guidance Document
Related news
- FDA announces new expedited program for devices expected to significantly improve the safety of existing technologiesjdsupra.com
- FDA quietly withdraws plans for a Devices Referencing Drugs regulatory approval pathwayjdsupra.com
- FDA Considers Approval Pathway for Medical Devices to Unilaterally Cross-Reference Marketed Drug Productsjdsupra.com
- Seeking to reduce premarket burdens, FDA proposes to expand Abbreviated 510(k) Pathway for certain devicesjdsupra.com
- FDA Issues Guidance Document on Animal Studies for the Evaluation of Medical Devicesjdsupra.com
- CMS Proposes Basic Changes for Medicare Coverage, Including a New Reimbursement Pathway for FDA-designated Breakthrough Medical Devicesjdsupra.com
- Expedited Access Program Begins For Medical Devicesjdsupra.com
- BSarepta Could Triple on Expedited FDA Approvalbarrons.com
- FDA Announces Plans for Alternative Clearance Pathwayjdsupra.com
- PAmgen cancer drug Kyprolis to get expedited review from FDApacbiztimes.com
- EPA Provides Expedited Pathway for Companies to Claim “Long-Lasting” Efficacy for Antiviral Productsjdsupra.com
- Outgoing FDA Commissioner Proposes Expedited Steps for Approval of CBDjdsupra.com
- U.S. PTO Initiates Expedited Review Process for COVID-19 Related Trademarksjdsupra.com
- FDA Report: Agency Announces Expedited Review of Certain ANDAsjdsupra.com
Patch to treat peanut allergies to get expedited FDA reviewseattletimes.com- Former FDA Commissioner Pushes Expedited Authorization for CBD Productsjdsupra.com
- New FDA pilot offers expedited drug program sponsors expanded FDA meeting opportunities on manufacturing issuesjdsupra.com
FDA to redo review of medical devicesnwaonline.com- FDA Issues Biosimilars Q&A Guidance Documentjdsupra.com